Similarly, in a study involving diabetic type 2 patients, serum levels of both FGF-21 and CK-18 were not evidently associated with the presence of NAFLD or liver fibrosis [59]. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.